Published on in Vol 7 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/64300, first published .
Improving Affordability in Dermatology: Cost Savings in Mark Cuban Cost Plus Drug Company Versus GoodRx

Improving Affordability in Dermatology: Cost Savings in Mark Cuban Cost Plus Drug Company Versus GoodRx

Improving Affordability in Dermatology: Cost Savings in Mark Cuban Cost Plus Drug Company Versus GoodRx

There are currently no tweets available for this article within the specified range.

Cookie Consent

We use our own cookies and third-party cookies so that we can show you this website and better understand how you use it, with a view to improving the services we offer. If you continue browsing, we consider that you have accepted the cookies.